ReleaseWire

NASDAQ:OM Investor Notice: Investigation Concerning Potential Violations of Securities Laws by Outset Medical, Inc.

An investigation for investors in Outset Medical, Inc. (NASDAQ:OM) shares over potential securities laws violations by Outset Medical, Inc. was announced.

Posted: Friday, July 01, 2022 at 12:15 PM CDT

San Diego, CA -- (SBWire) -- 07/01/2022 --An investigation on was announced over potential securities laws violations by Outset Medical, Inc. in connection with certain financial statements.

Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) concerning whether a series of statements by Outset Medical, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Jose, CA based Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis.

Outset Medical, Inc. reported that its annual Total Revenue rose from $49.93 million in 2020, to $102.6 million in 2021, and that its Net Loss increased from $121.49 million in 2020, to $131.93 million in 2021.

On June 13, 2022, Outset Medical, Inc. announced that "it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the Food and Drug Administration's (FDA) review and clearance of a 510(k) the company submitted for changes made since the device's original March 2020 clearance."

Shares of Outset Medical, Inc. (NASDAQ: OM) declined from $40.51 per share on May 4, 2022, to as low as $13.25 per share on June 14, 2022.

Those who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.